Controlled Trial of 2, 4, and 6 Months of Pyrazinamide in 6-Month, Three-Times-Weekly Regimens for Smear-positive Pulmonary Tuberculosis, Including an Assessment of a Combined Preparation of Isoniazid, Rifampin, and Pyrazinamide: Results at 30 Months.
Hong Kong Chest ServiceBritish Medical Research Council /
American Journal of Respiratory & Critical Care Medicine.
143(4_pt_1):700-706, April 1991.
(Format: HTML, PDF)